Cargando…
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B Vaccine
Autores principales: | Gerlich, Wolfram H., Glebe, Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049933/ https://www.ncbi.nlm.nih.gov/pubmed/27485030 http://dx.doi.org/10.1016/j.ebiom.2016.07.032 |
Ejemplares similares
-
Enigmatic PreS deletions in hepatitis B virus DNA
por: Gerlich, Wolfram H., et al.
Publicado: (2020) -
“Dual use”: The anti-allergy vaccine BM32 and its HBV carrier protein
por: Gerlich, Wolfram H.
Publicado: (2020) -
Functional cure of chronic hepatitis B – predictable?
por: Gerlich, Wolfram
Publicado: (2021) -
Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings
por: Gerlich, Wolfram H., et al.
Publicado: (2020) -
A Novel Insertion in the Hepatitis B Virus Surface Protein Leading to Hyperglycosylation Causes Diagnostic and Immune Escape
por: Lehmann, Felix, et al.
Publicado: (2023)